Exact Mass: 510.2914168
Exact Mass Matches: 510.2914168
Found 169 metabolites which its exact mass value is equals to given mass value 510.2914168
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPG(18:1(9Z)/0:0)
LysoPG(18:1(9Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:1(9Z)/0:0), in particular, consists of one chain of oleic acid at the C-1 position.
[1R-[1alpha(E),4beta,4abeta,5beta(E),6alpha,8aalpha]]-[4-(Acetyloxy)decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-2,4-pentadienyl)-1-naphthalenyl]methyl ester 3-(4-hydroxyphenyl)-2-propenoic acid
16-Diacetoxy-7alpha-hydroxy-18-malonyloxy-ent-cleroda-3-ene
[1R-[1alpha(Z),4beta,4abeta,5beta(E),6alpha,8aalpha]]-[4-(Acetyloxy)decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-2,4-pentadienyl)-1-naphthalenyl]methyl ester 3-(4-hydroxyphenyl)-2-propenoic acid
(20R)-15alpha-hydroxy-8beta,9alpha,14alpha,17alpha-pregn-4-en-3-one 20-O-beta-D-glucopyranoside
(2beta,3beta,5beta,22R)-2,3,14,20,22,25-Hexahydroxy-6-oxocholest-7-en-26-oic acid
11-hydroxy-7Halpha,10Hbeta-eremophil-4(15)-ene 11-O-beta-D-(3-O,4-O,6-O-triacetyl)glucopyranoside
24,25,26,27-tetranor-apotirucalla-(apoeupha)-1alpha-senecioyloxy-3alpha,7alpha-dihydroxy-14,20,22-trien-21,23-epoxy|meliacinolin
17-hydroxypregnanolone-glucuronide|O1-(17-hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronic acid|O1-(17-Hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronsaeure
ent-15,16-trihydroxypimar-8(14)-en-3-yl beta-glucopyranoside-15,16-acetonide
His Gln Val Lys
Phe Phe Val Val
Phe Val Phe Val
Phe Val Val Phe
His Ile Lys Asn
His Ile Asn Lys
His Lys Ile Asn
His Lys Leu Asn
His Lys Asn Ile
His Lys Asn Leu
His Lys Gln Val
His Lys Val Gln
His Leu Lys Asn
His Leu Asn Lys
His Asn Ile Lys
His Asn Lys Ile
His Asn Lys Leu
His Asn Leu Lys
His Gln Lys Val
His Val Lys Gln
His Val Gln Lys
Ile His Lys Asn
Ile His Asn Lys
Ile Lys His Asn
Ile Lys Asn His
Ile Asn His Lys
Ile Asn Lys His
Lys His Ile Asn
Lys His Leu Asn
Lys His Asn Ile
Lys His Asn Leu
Lys His Gln Val
Lys His Val Gln
Lys Ile His Asn
Lys Ile Asn His
Lys Leu His Asn
Lys Leu Asn His
Lys Asn His Ile
Lys Asn His Leu
Lys Asn Ile His
Lys Asn Leu His
Lys Gln His Val
Lys Gln Val His
Lys Val His Gln
Lys Val Gln His
Leu His Lys Asn
Leu His Asn Lys
Leu Lys His Asn
Leu Lys Asn His
Leu Asn His Lys
Leu Asn Lys His
Asn His Ile Lys
Asn His Lys Ile
Asn His Lys Leu
Asn His Leu Lys
Asn Ile His Lys
Asn Ile Lys His
Asn Lys His Ile
Asn Lys His Leu
Asn Lys Ile His
Asn Lys Leu His
Asn Leu His Lys
Asn Leu Lys His
Gln His Lys Val
Gln His Val Lys
Gln Lys His Val
Gln Lys Val His
Gln Val His Lys
Gln Val Lys His
Val Phe Phe Val
Val Phe Val Phe
Val His Lys Gln
Val His Gln Lys
Val Lys His Gln
Val Lys Gln His
Val Gln His Lys
Val Gln Lys His
Val Val Phe Phe
PG(18:1/0:0)[U]
PG(18:1/0:0)
LPG 18:1
Ethyl acrylate-acrylic acid-2-ethylhexyl acrylate-N-methylolacrylamide-acrylonitrile polymer
N-(butoxymethyl)prop-2-enamide,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile,2-methylprop-2-enoic acid
(5R)-2,5,6-trihydroxy-2-methyl-6-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-octadec-11-enoate
Longirostrerone B
An azaphilone that is 7,8-dihydro-6H-isochromen-6-one substituted by a hydroxy group at position 7, a 4-hydroxy-2-methyl-6-oxocyclohexyl group at position 3, a methyl group at position 7 and a 5,7,9-trimethyl-2-oxoundeca-3,5-dien-1-yl group at position 8. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.
1-Heptadecanoyl-sn-glycero-3-phosphoserine(1-)
C23H45NO9P- (510.2831790000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
[3-[[(2S)-2,3-Dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (E)-octadec-9-enoate
(2S)-3-({[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropyl (9Z)-octadec-9-enoate
(2S)-1-({[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate
(2R)-1-({[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate
[(2R)-2-(5-hydroxypentanoyloxy)-3-phosphonooxypropyl] hexadecanoate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-octadec-9-enoate
1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-sn-glycerol)
(3r,4r,4's,6r,6''s,9s,9''s,9ar,9''ar)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
C30H42N2O3S (510.29159820000007)
2-[(2-{[2-(2-amino-n,3-dimethylbutanamido)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene)amino]benzoic acid
2-{[(2s)-2-{[(2r)-2-[(2s,3r)-2-amino-n,3-dimethylpentanamido]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}benzoic acid
(2e,5r)-5-{[(8r)-7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-6-[(2r)-2-methylbutanoyl]-5-oxochromen-8-yl]methyl}-2,6-dimethylhepta-2,6-dienoic acid
(3r,4s,4'r,6s,6''s,9r,9''r,9as,9''as)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
C30H42N2O3S (510.29159820000007)